Testing and treating sleep apnea in patients with atrial fibrillation
Official title: STAROSA Trial - Structured Testing and Treatment for Obstructive Sleep Apnea in Patients With Atrial Fibrillation
Run by University Hospital, Antwerp · NCT06263608 · Data updated 2026-11-12
This study tests whether a new program for diagnosing and treating sleep apnea can help people with atrial fibrillation feel better and reduce their heart rhythm problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 209 (estimated) |
| Sponsor | University Hospital, Antwerp Academic / other |
| Locations | 2 sites (Edegem and 1 other locations) |
| Status | Recruiting |
| Started | February 23, 2024 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT06263608 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 diagnosed with paroxysmal or persistent atrial fibrillation who experience symptoms and own a compatible smartphone.
✕Probably not a fit
Patients with permanent atrial fibrillation, cognitive impairments, or those currently undergoing CPAP treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of a structured testing and treatment program for obstructive sleep apnea in patients diagnosed with atrial fibrillation. Participants will use the NOX T3s device for home-based respiratory polygraphy, and those diagnosed with obstructive sleep apnea will undergo further evaluation and treatment, primarily using continuous positive airway pressure (CPAP). The study also incorporates the use of a Fitbit smartwatch to monitor patients over a six-month period, assessing their symptoms and satisfaction with the treatment. The goal is to improve the recognition and management of obstructive sleep apnea in this population, potentially reducing atrial fibrillation recurrence.
Why it matters
Potential benefit: If successful, this approach could lead to better management of obstructive sleep apnea in atrial fibrillation patients, potentially reducing the frequency of AF episodes.
How similar studies have gone: Previous studies have shown promising results using similar home-based polygraphy devices for diagnosing obstructive sleep apnea, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients in whom AF (paroxysmal or persistent) is diagnosed with a 12-lead ECG * Patients who experience symptoms of their AF (mEHRA ≥ 2a) * Older than 18 years * Owning a smartphone compatible with Fitbit and FibriCheck applications (i.e. recent versions of Apple iOS or Android drivers) * Ability to sign the informed consent Exclusion Criteria: * Patients diagnosed with permanent AF or only atrial flutter * Prior/recent polysomnography evaluation * Prior/active CPAP/BiPAP/ASV treatment * Cognitive impairment * Inability to speak or fully understand Dutch * Pacemaker-dependent heart rhythm
Where it's running
-
University Hospital of Antwerp
Edegem, Belgium Recruiting -
Jessa Hospital
Hasselt, Belgium Recruiting
Study contacts
- Principal investigator: Hein Heidbuchel, MD, PhD — University Hospital of Antwerp
- Study coordinator: Lien Desteghe, MSc, PhD
- Email: lien.desteghe@uza.be
- Phone: +32 3 821 33 06
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating Atrial Fibrosis in Patients with Obstructive Sleep Apnea
This study is trying to see if people with obstructive sleep apnea are more likely to develop atrial fibrosis compared to those without the condition.
-
Impact of sleep apnea on heart health in patients with atrial fibrillation
This study is testing how sleep apnea affects heart health in people with atrial fibrillation to see if it changes their risk of heart problems.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.